a scaffold protein that connects plasma membrane proteins with members of the Ezrin/moesin/radixin family and thereby helps to link them to the actin cytoskeleton and to regulate their surface expression. Necessary for recycling of internalized beta-2-adrenergic receptor Was first known to play a role in the regulation of the activity and subcellular location of SLC9A3. Necessary for cAMP-mediated phosphorylation and inhibition of SLC9A3. May enhance Wnt signaling. Note: This description may include information from UniProtKB.
Protein type: Motility/polarity/chemotaxis; Adaptor/scaffold
Molecular Function: protein binding; chloride channel regulator activity; protein self-association; beta-2 adrenergic receptor binding; protein complex binding; beta-catenin binding; dopamine receptor binding; protein complex scaffold; PDZ domain binding; phosphatase binding; receptor binding
Biological Process: bile acid secretion; Wnt receptor signaling pathway; establishment of nucleus localization; negative regulation of protein kinase B signaling cascade; establishment of epithelial cell polarity; renal sodium ion transport; regulation of cell shape; negative regulation of cell proliferation; microvillus biogenesis; sensory perception of sound; cellular phosphate ion homeostasis; establishment of Golgi localization; regulation of sodium:hydrogen antiporter activity; gland morphogenesis; protein complex assembly; negative regulation of mitotic cell cycle; auditory receptor cell stereocilium organization and biogenesis; dopamine receptor, phospholipase C activating pathway; actin cytoskeleton organization and biogenesis; regulation of protein kinase activity; negative regulation of sodium:hydrogen antiporter activity; negative regulation of cell migration; regulation of cell size; negative regulation of phosphoinositide 3-kinase cascade; dopamine receptor, adenylate cyclase activating pathway
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.